Xeptiva is a biotechnology company developing therapies for the treatment of chronic inflammation in companion animals
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Montevideo
State: NA - Uruguay
Zip:
Country: Uruguay
Xeptiva Therapeutics is a veterinary biotechnology company that focuses on developing therapies for chronic inflammation conditions in companion animals. Its main products target chronic pain associated with osteoarthritis and atopic dermatitis in dogs. In addition, the company is developing therapies for the treatment of pain in horses and asthma in cats. Xeptiva&s;s goal is to allow pets to live longer and healthier by targeting the underlying source of many chronic diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2021 | Pre Seed Round | $500k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|